NDC 0068-0599
Rifadin IV NOVAPLUS
Rifampin
Rifadin IV NOVAPLUS is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifampin.
Product ID | 0068-0599_0b052072-4d59-4847-adc9-0c9b56f11f2c |
NDC | 0068-0599 |
Product Type | Human Prescription Drug |
Proprietary Name | Rifadin IV NOVAPLUS |
Generic Name | Rifampin |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2017-02-01 |
Marketing Category | NDA / NDA |
Application Number | NDA050627 |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | RIFAMPIN |
Active Ingredient Strength | 600 mg/10mL |
Pharm Classes | Rifamycin Antibacterial [EPC],Rifamycins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |